Irwin Naturals Corporate Overview
The Bottom Line
We know how to
build a dominant
brand and deliver
on our projections.
We plan to
do the same in
cannabis and
psychedelics.
2021 nutraceuticals business tracking to US $134 million.
Highest grossing and most profitable year ever. Profitable
for 27 consecutive years.*
2021 adjusted EBITDA expected to increase by 61% over
2020, from about US $8.3 million to US $13.3 million.
Household name mega-brand known by over 100 million
Americans and Canadians and sold in about 100,000 major
big-box retail locations.
Cannabis and psychedelics launch planned in 2021 to
provide Coca-Cola-like first-mover advantage among
mega-brand peers hoping to move into these categories.
Deep team experience to exploit disruptive new
opportunities while maintaining profitability. We've
disrupted before and are about to do it again in a space
where the competition doesn't have our skillset or the
same quality of distribution relationships.
*Under several corporate structures, Klee Irwin has operated the Irwin brand
profitably since 1994, as measured by EBITDA adjusted for extraordinary costs.
5View entire presentation